Genzyme’s Renvela Approved For Kidney Disease Patients On Dialysis
This article was originally published in The Pink Sheet Daily
Executive Summary
Filing for predialysis indication is on track for first half of 2008 after “positive” outcome of FDA Cardio-Renal Advisory Committee meeting, Genzyme Renal President Butler tells “The Pink Sheet” DAILY.
You may also be interested in...
Genzyme: Next-Generation Sevelamer Bound For Clinic Next Year
Enzyme-replacement sales strong as firm builds on renal franchise.
Genzyme: Next-Generation Sevelamer Bound For Clinic Next Year
Enzyme-replacement sales strong as firm builds on renal franchise.
Advisory Committee Rejects Surrogate Endpoint For Phosphate Binders
Sponsors are seeking to expand the indication of the CKD therapies without clinical data.